Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Coherus Biosciences (CHRS) Q1 2023 Earnings
CHRS
8
May
Confirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.96
-0.8
-0.63
-0.47
Details
Expected EPS
-0.57
Actual EPS
-0.75
Surprise EPS
-0.18
Surprise Percent
+31.58%
Description
Coherus Biosciences (CHRS) has reported earnings of -0.75 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login